Crystal Structure of (E)-N-(2-bromophenyl)-4-(4-(3,5-dimethoxystyryl)phenoxy)pyrimidin-2-amine, C26H22BrN3O3

Wuji Sun,Lixin Sun,Hong Yan

DOI: https://doi.org/10.1515/ncrs-2024-0187

2024-01-01

Abstract:C26H22BrN3O3, monoclinic, P21/c (no. 14), a = 17.7467(15) Å, b = 10.7974(8) Å, c = 11.9136(8) Å, β = 96.084°, V = 2270.0(3) Å3, Z = 4, Rgt (F) = 0.0375, wRref (F 2) = 0.1205, T = 293 K.

What problem does this paper attempt to address?

Crystal structure of ( E )- N -(2-bromophenyl)-4-(4-(3,5-dimethoxystyryl)phenoxy)pyrimidin-2-amine, C 26 H 22 BrN 3 O 3

Wuji Sun,Lixin Sun,Hong Yan

DOI: https://doi.org/10.1515/ncrs-2024-0187

2024-06-21

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 26 H 22 BrN 3 O 3 , monoclinic, P 2 1 / c (no. 14), a = 17.7467(15) Å, b = 10.7974(8) Å, c = 11.9136(8) Å, β = 96.084°, V = 2270.0(3) Å 3 , Z = 4, R gt ( F ) = 0.0375, wR ref ( F 2 ) = 0.1205, T = 293 K.

crystallography
Crystal Structure of 2-(1-benzyl-3-phenyl-1h-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S

Xu-Wen Huang,Jin-Zong You,Wan-Min Ni,Yi-Ping Zhang,Qi Feng,Wen-Chang Xu,Sheng-Yue Tong,Tang-Qi Li,De-Qiang Qi

DOI: https://doi.org/10.1515/ncrs-2016-0262

2017-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C25H19N5O3S, monoclinic, P21/c (no. 14), a = 16.715(2) Å, b = 11.2677(15) Å, c = 12.6490(17) Å, β = 110.818(2)°, V = 2226.7(5) Å3, Z = 4, Rgt(F) = 0.0424, wRref(F2) = 0.1037, T = 296 K.
Crystal Structure of 5-(4-pyridyl)pyrimidine–4,4′-bipyridine–1,3,5-benzenetriol–water (1:1:1:1), C25H23N5O4

Wen-Jun Xu,De-Qiang Qi,Jin-Zong You,Xue-Jie Wang,Yi-Ping Zhang,Fei-Fei Hu,Jia-Ying Bian,Chun-Xia Yang,Juan Huang

DOI: https://doi.org/10.1515/ncrs-2015-0083

2016-01-01

Abstract:C25H23N5O4, triclinic, P1̅ (no. 2), a = 8.157(2) Å, b = 9.262(2) Å, c = 15.465(4) Å, α = 87.887(4)°, β = 89.803(4)°, γ = 72.727(4)°, V = 1114.9(5) Å3, Z = 2, Rgt(F) = 0.0755, wRret(F2) = 0.184, T = 298 K.
Crystal Structure of Ethyl 1-(4-fluorobenzyl)-3-phenyl-1h-pyrazole-5-carboxylate, C19H17FN2O2

Sheng-Yue Tong,Jin-Zong You,Yi-Ping Zhang,Zhen-Zhen Wang,Ke-Ji Yu,Qiong Hu,Hui-Juan Pan,Cheng-Jie Wu,De-Qiang Qi

DOI: https://doi.org/10.1515/ncrs-2017-0266

2018-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:Abstract C19H17FN2O2, triclinic, P1̅ (no. 2), a = 7.8593(19) Å, b = 10.3322(18) Å, c = 10.9747(19) Å, α = 108.914(18)°, β = 92.931(3)°, γ = 99.544(3)°, V = 826.1(3) Å3, Z = 2, R gt(F) = 0.0431, wR ref(F 2) = 0.1170, T = 296.15 K.
The Crystal Structure of (E)-3-chloro-2-(2-(2-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3

Hui-Zhen Wu,Li-Jing Min,Liang Han,Xing-Hai Liu,Na-Bo Sun

DOI: https://doi.org/10.1515/ncrs-2021-0164

2021-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C12H9ClFN3, monoclinic, C2/c (no. 15), a = 24.713(13) Å, b = 15.459(13) Å, c = 17.507(12) Å, β = 17.515(11)°, V = 4742(6) Å3, Z = 16, Rgt(F) = 0.0530, wRref(F2) = 0.1161, T = 113(2) K.
Crystal Structure of 4-(5-((2-methylbenzyl)thio)-4-phenyl-4h-1,2,4-triazol-3-yl)pyridine, C21H18N4S

Guo-Xiang Sun,Zhao-Hui Sun,Ming-Yan Yang,Hong-Ke Wu

DOI: https://doi.org/10.1515/ncrs-2016-0106

2016-01-01

Abstract:C21H18N4S, monoclinic, P21/c (no. 14), a = 18.264(2) Å, b = 11.6302(14) Å, c = 8.9289(10) Å, β = 101.683(7)°, V = 1857.3(4) Å3, Z = 4, Rgt(F) = 0.0435, wRref(F2) = 0.1122, T = 296(2) K.
Crystal Structure of Tris(4-(Pyridin-4-yl)phenyl)amine, Dihydrate, (C33H24N4)·2(H2O), C33H28N4O2

Lei Cao,Le Zhou,Guo-Hui Kang,Chuan-Sheng Ruan,Bao-Ming Ji

DOI: https://doi.org/10.1524/ncrs.2013.0160

2013-01-01

Abstract:Abstract C33H28N4O2, monoclinic, P21/c (no. 14), a = 10.263(8) Å, b = 23.48(2) Å, c = 12.28(1) Å, β = 114.498(9)°, V = 2692.9 Å3, Z = 4, Rgt(F) = 0.0451, wRref(F2) = 0.1189, T = 296 K.
The Crystal Structure of 2-Phenyl-4,6-bis(prop-2-yn-1-yloxy)-1,3,5-triazine, C15H11N3O2

Jin Li,Yan Chen,Ziqing Wu,Yali Liu,Dachuan Yin,Zhenyu Zuo

DOI: https://doi.org/10.1515/ncrs-2019-0733

2019-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C15H11N3O2, triclinic, P1̄ (no. 2), a = 8.4680(5) Å, b = 9.7578(5) Å, c = 10.2101(6) Å, α = 104.578(5)°, β = 111.882(6)°, γ = 106.589(5)°, V = 686.77(8) Å3, Z = 2, Rgt(F) = 0.0394, wRref(F2) = 0.1261, T = 250(2) K.
The crystal structure of N -[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-(2-methylphenyl)-2-sulfanylprop-2-enamide hydrate, C 19 H 17 BrN 2 O 2 S 2

Lei-Qiang Ni,Xiao-Meng Guo,Ze-Lin Wang,Juan Sun

DOI: https://doi.org/10.1515/ncrs-2024-0009

2024-03-14

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 19 H 17 BrN 2 O 2 S 2 , triclinic, P 1 ̅ (no. 2), a = 7.8069(5) Å, b = 8.0787(5) Å, c = 15.7738(9) Å, α = 97.540(2)°, β = 90.179(2)°, γ = 104.507(2)°, V = 954.13(10) Å 3 , Z = 2, R gt ( F ) = 0.0423, wR ref ( F 2 ) = 0.1134, T = 296.15 K.

crystallography
Crystal Structure of 4-(((2-(3-(1-(3-(3-cyanophenyl)-6-oxopyridazin-1(6h)-yl)ethyl)phenyl) Pyrimidin-5-yl)oxy)methyl)-1-methylpiperidin-1-ium Chloride Monohydrate, C30H33N6O2Cl

Han Yao,Ming Yan,Xingshu Li,Jinhui Hu

DOI: https://doi.org/10.1515/ncrs-2022-0087

2022-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C30H33N6O2Cl monoclinic, P21 (no. 4), a = 13.7983(8) Å, b = 7.3771(3) Å, c = 14.3578(7) Å, β = 101.730(5)°, V = 1430.97(12) Å3, Z = 2, R gt(F) = 0.0525, wR ref(F 2) = 0.1285, T = 170 K.
The crystal structure of tris(2-bromo-4-methylphenyl)amine, C 21 H 18 Br 3 N

Bingcui Yang,Xiaofang Jing,Yuanxiao Meng,Liangli Zhong,Hao Cui

DOI: https://doi.org/10.1515/ncrs-2024-0352

2024-10-17

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 21 H 18 Br 3 N, monoclinic, P 2 1 / c (no. 14), a = 17.0082(5) Å, b = 7.70818(16) Å, c = 15.8792(5) Å, β = 105.108 ( 3 ) ° , V = 2009.83(10) Å 3 , Z = 4, R gt ( F ) = 0.0594, wR ref ( F 2 ) = 0.1687, T = 100 K.

crystallography
Crystal Structure of (Z)-2-(4-((5-bromopentyl)oxy)benzylidene)-4,5,6-trimethoxybenzofuran-3(2h)-one, C23H25BrO6

Hua-Bin Wang,Long Xu,Jing-Min Shi,Ying Zhou,Yong‐Jia Hao

DOI: https://doi.org/10.1515/ncrs-2023-0329

2023-01-01

Abstract:C 23 H 25 BrO 6 , triclinic, P 1 ‾ $\overline{1}$ (no. 2), a = 7.8451(3) Å, b = 7.9428(2) Å, c = 17.6360(6) Å, α = 90.146(3), β = 90.433(3) ∘ , γ = 99.307(3) ∘ , V = 1084.44(7) Å 3 , Z = 2, R gt ( F ) = 0.0464, wR ref ( F 2 ) = 0.1402, T = 297.37(10) K.
Crystal Structure of (S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-3-methoxy-6-oxopyridazin-1(6h)-yl)-3-phenylpropanamido)benzoic Acid Monohydrate, C29H26ClN3O7

Wen-Jie Xu,Ying Xiao,Duan-Ming Tan,Song Li

DOI: https://doi.org/10.1515/ncrs-2024-0246

2024-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C29H26ClN3O7, monoclinic, P21 (no. 4), a = 15.5488(6) Å, b = 7.9366(3) Å, c = 22.6498(9) Å, β = 93.006(2)°, V = 2,791.24(19) Å3, Z = 4, R gt (F) = 0.0528, wR ref (F 2) = 0.1391, T = 292 K.
The crystal structure of 2-(2-((4,6-dimethoxypyrimidin-2-yl)oxy)phenyl)-4-(piperidin-1-yl)-5 H -chromeno[2,3- d ]pyrimidine, C 28 H 27 N 5 O 4

Dongtai Xie,Sufang Lei,Yuanxiang Li

DOI: https://doi.org/10.1515/ncrs-2023-0511

2024-01-25

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 28 H 27 N 5 O 4 , monoclinic, P 2 1 / c (no. 14), a = 11.3563(15) Å, b = 17.547(2) Å, c = 12.8390(16) Å, β = 101.385(3)°, V = 2508.1(6) Å 3 , Z = 4, R gt ( F ) = 0.0538, wR ref ( F 2 ) = 0.1329, T = 292(2) K.

crystallography
Crystal Structure of N2,N6-bis(2-(((Z)-5-bromo-2-hydroxybenzylidene)amino) Phenyl)pyridine-2,6-dicarboxamide, C33H23Br2N5O4

Wen-Ze Zhao,Lei Zhang,Na Zhang

DOI: https://doi.org/10.1515/ncrs-2023-0432

2024-01-01

Abstract:C33H23Br2N5O4, triclinic, P (1) over bar (no. 2), a = 10.649(3) angstrom, b = 11.244(3) angstrom, c = 14.301(4) angstrom, alpha = 68.254(7)degrees, beta = 72.939(7)degrees, gamma = 81.125(7)degrees, V = 1518.5(7) angstrom(3), Z = 2, R-gt(F) = 0.0514, wR(ref)(F-2) = 0.1327, T = 273(2) K.
Crystal structure of N -(4-bromobenzyl)-3-(difluoromethyl)-1-methyl- N -(pyridin-2-yl)-1 H -pyrazole-4-carboxamide, C 18 H 15 BrF 2 N 4 O

Ya-Li Liu,Hua-Jin Zhang,Juan Luo,Shang-Xing Chen,Ji Zhang

DOI: https://doi.org/10.1515/ncrs-2023-0513

2024-01-14

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 18 H 15 BrF 2 N 4 O, monoclinic, C2/c (no. 15), a = 22.984(4) Å, b = 10.0726(16) Å, c = 16.551(3) Å, β = 107.972(2)°, V = 3644.8(10) Å 3 , Z = 8, R gt (F) = 0.0412, wR ref (F 2 ) = 0.1051, T = 296(2) K.

crystallography
Crystal Structure of 2-(2-naphthyl)-4,6-dimethylpyrimidine, C16H14N2

Li-Ming Qiang,Jun-Ling Si,Xin-Ming Dong,Xin-Qi Hao,Kui Lu,Yu-Fen Zhao

DOI: https://doi.org/10.1524/ncrs.2011.0149

2011-01-01

Abstract:C16H14N2, monoclinic, P12(1)/c1 (no. 14), a = 8.387(1) angstrom, b = 17.453(3) angstrom, c = 8.694(1) angstrom, beta = 93.092(2)degrees, V = 1270.8 angstrom(3), Z = 4, R-gt(F) = 0.046, wR(ref)(F-2) = 0.129, T = 294 K.
The Crystal Structre of 2-(4-bromophenyl)-2,3-dihydro-1h-naphtho[1,8-de][1,3,2]diazaborinine, C16H12BBrN2

Siyi Ding,Min Zhu,Zong-Cheng Miao

DOI: https://doi.org/10.1515/ncrs-2020-0556

2020-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C16H12BBrN2, monoclinic, P21 (no. 4), a = 4.7061(3) Å, b = 10.4639(6) Å, c = 13.5675(8) Å, β = 97.512(2)°, V = 662.39(7) Å3, Z = 2, Rgt(F) = 0.0384, wRref(F2) = 0.0995, T = 189.98 K.
Crystal Structure of Ethyl 2-Amino-4-(3,4-dimethylphenyl)-5-oxo-4h,5h-pyrano[3,2-c] Chromene-3-carboxylate, C23H21NO5

Xue-Kun Liu,Xiao-Yu Geng,Meng Zhang,Bai-Jun Ye,Zhan Shi,Yan-Qiu Wang

DOI: https://doi.org/10.1515/ncrs-2018-0023

2018-01-01

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:Abstract C23H21NO5, monoclinic, P21/c (no. 14), a = 15.829(11) Å, b = 8.294(6) Å, c = 14.718(10) Å, β = 93.339(12)°, V = 1929(2) Å3, Z = 4, R gt(F) = 0.073, wR ref(F 2) = 0.206, T = 296(2) K.
The crystal structure of (E) -2-chloro-5-((2-(nitromethylene)imidazolidin-1-yl)methyl)pyridine, C 10 H 11 ClN 4 O 2

Zhen Chen,Kang Guo,Yanwen Sun,Chang Liu,Sijun Li

DOI: https://doi.org/10.1515/ncrs-2024-0045

2024-03-28

Zeitschrift für Kristallographie - New Crystal Structures

Abstract:C 10 H 11 ClN 4 O 2 , monoclinic, P 2 1 / c (no. 14), a = 12.7802(17) Å, b = 7.6211(12) Å, c = 12.0486(17) Å, β = 95.551(4)°, V = 1168.0(3) Å 3 , Z = 4, R gt ( F ) = 0.0562, w R ref ( F 2 ) = 0.1172, T = 273(2) K.

crystallography

Crystal Structure of (E)-N-(2-bromophenyl)-4-(4-(3,5-dimethoxystyryl)phenoxy)pyrimidin-2-amine, C26H22BrN3O3

Crystal structure of ( E )- N -(2-bromophenyl)-4-(4-(3,5-dimethoxystyryl)phenoxy)pyrimidin-2-amine, C 26 H 22 BrN 3 O 3

Crystal Structure of 2-(1-benzyl-3-phenyl-1h-pyrazol-5-yl)-5-(4-nitrobenzylthio)-1,3,4-oxadiazole, C25H19N5O3S

Crystal Structure of 5-(4-pyridyl)pyrimidine–4,4′-bipyridine–1,3,5-benzenetriol–water (1:1:1:1), C25H23N5O4

Crystal Structure of Ethyl 1-(4-fluorobenzyl)-3-phenyl-1h-pyrazole-5-carboxylate, C19H17FN2O2

The Crystal Structure of (E)-3-chloro-2-(2-(2-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3

Crystal Structure of 4-(5-((2-methylbenzyl)thio)-4-phenyl-4h-1,2,4-triazol-3-yl)pyridine, C21H18N4S

Crystal Structure of Tris(4-(Pyridin-4-yl)phenyl)amine, Dihydrate, (C33H24N4)·2(H2O), C33H28N4O2

The Crystal Structure of 2-Phenyl-4,6-bis(prop-2-yn-1-yloxy)-1,3,5-triazine, C15H11N3O2

The crystal structure of N -[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-(2-methylphenyl)-2-sulfanylprop-2-enamide hydrate, C 19 H 17 BrN 2 O 2 S 2

Crystal Structure of 4-(((2-(3-(1-(3-(3-cyanophenyl)-6-oxopyridazin-1(6h)-yl)ethyl)phenyl) Pyrimidin-5-yl)oxy)methyl)-1-methylpiperidin-1-ium Chloride Monohydrate, C30H33N6O2Cl

The crystal structure of tris(2-bromo-4-methylphenyl)amine, C 21 H 18 Br 3 N

Crystal Structure of (Z)-2-(4-((5-bromopentyl)oxy)benzylidene)-4,5,6-trimethoxybenzofuran-3(2h)-one, C23H25BrO6

Crystal Structure of (S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-3-methoxy-6-oxopyridazin-1(6h)-yl)-3-phenylpropanamido)benzoic Acid Monohydrate, C29H26ClN3O7

The crystal structure of 2-(2-((4,6-dimethoxypyrimidin-2-yl)oxy)phenyl)-4-(piperidin-1-yl)-5 H -chromeno[2,3- d ]pyrimidine, C 28 H 27 N 5 O 4

Crystal Structure of N2,N6-bis(2-(((Z)-5-bromo-2-hydroxybenzylidene)amino) Phenyl)pyridine-2,6-dicarboxamide, C33H23Br2N5O4

Crystal structure of N -(4-bromobenzyl)-3-(difluoromethyl)-1-methyl- N -(pyridin-2-yl)-1 H -pyrazole-4-carboxamide, C 18 H 15 BrF 2 N 4 O

Crystal Structure of 2-(2-naphthyl)-4,6-dimethylpyrimidine, C16H14N2

The Crystal Structre of 2-(4-bromophenyl)-2,3-dihydro-1h-naphtho[1,8-de][1,3,2]diazaborinine, C16H12BBrN2

Crystal Structure of Ethyl 2-Amino-4-(3,4-dimethylphenyl)-5-oxo-4h,5h-pyrano[3,2-c] Chromene-3-carboxylate, C23H21NO5

The crystal structure of (E) -2-chloro-5-((2-(nitromethylene)imidazolidin-1-yl)methyl)pyridine, C 10 H 11 ClN 4 O 2